33525
DrugDaily for 14 days
NCT Number: NCT01396811
The purpose of this study is to determine if a topical antifungal cream is safe and effective for the treatment of tinea pedis.
Looking for future studies?
Notify Me12 year and older
All sexes
Interventional
Phase 3
Belize City, Belize
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Daily for 14 days
Daily for 14 days
Time frame: Day 42
Signs and Symptoms Severity Score and negative Potassium Hydroxide (KOH) and Culture
Time frame: Day 42
Clinical Cure and Mycologic Cure
Medicis Global Service Corporation
Industry
A Randomized, Multi-Center, Double-Blind, Vehicle-Controlled Study Evaluating the Efficacy and Safety of Product 33525 in Subjects With Tinea Pedis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04152226
Bacterial Infections and Mycoses, Dermatomycoses
Santo Domingo, Dominican Republic
View Trial DetailsNCT00233493
Bacterial Infections and Mycoses, Dermatomycoses
Cleveland, Ohio, United States
View Trial DetailsNCT05363449
Bacterial Infections and Mycoses, Dermatitis
San Diego, California, United States
View Trial DetailsNCT03129321
Bacterial Infections and Mycoses, Dermatomycoses
View Trial Details